Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome
Study author Sun H Kim, MD, MS, Associate Professor of Medicine in the Division of Endocrinology, Gerontology, and Metabolism at Stanford, summarized the findings to to Medical News Today , saying: We found that semaglutide compared to other weight loss medications, including another GLP-1 medication called dulaglutide, reduced risk of future fractures despite being associated with greater weight loss. Overall, semaglutide was linked to a bigger decrease in BMI
Cells grown from biopsies taken before and after treatment, showed a 6.5-fold increase in GT activity following treatment (Lewis et al., 1988)
Animal data predominates
Consult with a healthcare professional to determine the best usage and dosage for your needs and experience the transformative effects of this exceptional product.